Inflammatory biomarkers and delirium: a Mendelian randomization study

Miao Yu1, Yuxuan Li2, Baohua Li1

  • 1Department of Nursing, Peking University Third Hospital, Beijing, China.

PubMed
Abstract

Insights

This study found no causal link between common inflammatory biomarkers and delirium risk. Further research is needed to understand the role of inflammation in delirium development.

Area of Science:

  • Genetics
  • Immunology
  • Neuroscience

Background:

  • The relationship between inflammatory markers and delirium symptoms is debated.
  • Observational studies show inconsistent associations.
  • Causal links require robust investigation.

Purpose of the Study:

  • To investigate the causal relationship between inflammatory biomarkers and delirium risk.
  • To utilize Mendelian randomization to assess genetic associations.
  • To explore potential bidirectional causality.

Main Methods:

  • Bidirectional two-sample Mendelian randomization (MR) was employed.
  • Genetic instruments for 9 inflammatory biomarkers were identified from large GWAS.
  • Summary statistics for delirium were obtained from the FinnGen consortium.

Main Results:

  • Soluble IL-6 receptor alpha (sIL-6Rα) showed a potential association with decreased delirium risk at a stringent genome-wide significance level (P < 5e-8).
  • This association became non-significant with a more liberal threshold (P < 5e-6).
  • No significant causal effects were found for other tested inflammatory biomarkers (TNF-α, CRP, IL-1α, IL-1β, IL-2, IL-6, IL-8, soluble gp130) or reverse causation.

Conclusions:

  • This MR analysis does not support a causal association between the investigated peripheral inflammatory biomarkers and delirium.
  • Further research is necessary to elucidate the role of inflammatory factors in delirium pathogenesis.